Clinicopathologic features of lung cancer patients harboring de novo EGFR T790M mutation

被引：1
|
作者：
Lee, Young Joo
Lee, Geon Kook
Lee, Yeon-Su
机构：
[1] Natl Canc Ctr, Goyang, South Korea
[2] Natl Canc Ctr, Div Convergence Technol, Goyang, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.8075
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8075
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Detection of low-level EGFR T790M mutation in lung cancer tissues
    Oh, Ji Eun
    An, Chang Hyeok
    Yoo, Nam Jin
    Lee, Sug Hyung
    APMIS, 2011, 119 (07) : 403 - 411
  • [22] Clinical Likelihood of Sporadic Primary EGFR T790M Mutation in EGFR-Mutant Lung Cancer
    Lee, Youngjoo
    Lee, Geon Kook
    Hwang, Jung-Ah
    Yun, Tak
    Kim, Heung Tae
    Lee, Jin Soo
    CLINICAL LUNG CANCER, 2015, 16 (01) : 46 - 50
  • [23] HIGH PREVALENCE OF GERMLINE EGFR T790M MUTATIONS IN LUNG CANCER PATIENTS WHOSE TUMORS HARBOR BASELINE T790M
    Oxnard, Geoffrey R.
    Arcila, Maria E.
    Kris, Mark G.
    Ladanyi, Marc
    Miller, Vincent A.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S510 - S511
  • [24] Osimertinib in Combination with Bevacizumab Fails in Advanced Lung Adenocarcinoma Harboring EGFR T790M
    Zhang, Xiaoying
    GLOBAL MEDICAL GENETICS, 2021, 08 (04): : 133 - 134
  • [25] Generation of lung cancer cell lines harboring EGFR T790M mutation by CRISPR/Cas9-mediated genome editing
    Park, Mi-Young
    Jung, Min Hee
    Eo, Eun Young
    Kim, Seokjoong
    Lee, Sang Hoon
    Lee, Yeon Joo
    Park, Jong Sun
    Cho, Young Jae
    Chung, Jin Haeng
    Kim, Cheol Hyeon
    Yoon, Ho Il
    Lee, Jae Ho
    Lee, Choon-Taek
    ONCOTARGET, 2017, 8 (22) : 36331 - 36338
  • [26] The EGFR gatekeeper mutation T790M is present in selected patients with early breast cancer
    Bemanian, Vahid
    Sauer, Torill
    Touma, Joel
    Lindstedt, Bjorn A.
    Chen, Ying
    Odegard, Hilde P.
    Bukholm, Ida R.
    Geisler, Jurgen
    CANCER RESEARCH, 2015, 75
  • [27] Real-life efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer harboring EGFR T790M mutation
    Auliac, Jean Bernard
    Perol, Maurice
    Planchard, David
    Monnet, Isabelle
    Wislez, Marie
    Doubre, Helene
    Guisier, Florian
    Pichon, Eric
    Greillier, Laurent
    Mastroianni, Benedicte
    Decroisette, Chantal
    Schott, Roland
    Le Moulec, Sylvestre
    Arrondeau, Jennifer
    Cortot, Alexis B.
    Geriniere, Laurence
    Renault, Aldo
    Daniel, Catherine
    Falchero, Lionel
    Chouaid, Christos
    LUNG CANCER, 2019, 127 : 96 - 102
  • [28] Plasma EGFR liquid biopsy test in the assessment of exon 20 T790M mutation in lung cancer patients
    Lantos, A.
    Toth, E.
    VIRCHOWS ARCHIV, 2018, 473 : S310 - S311
  • [29] Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR
    Daphne W Bell
    Ira Gore
    Ross A Okimoto
    Nadia Godin-Heymann
    Raffaella Sordella
    Roseann Mulloy
    Sreenath V Sharma
    Brian W Brannigan
    Gayatry Mohapatra
    Jeff Settleman
    Daniel A Haber
    Nature Genetics, 2005, 37 : 1315 - 1316
  • [30] Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR
    Bell, DW
    Gore, I
    Okimoto, RA
    Godin-Heymann, N
    Sordella, R
    Mulloy, R
    Sharma, SV
    Brannigan, BW
    Mohapatra, G
    Settleman, J
    Haber, DA
    NATURE GENETICS, 2005, 37 (12) : 1315 - 1316
12345